Addition of pamidronate to chemotherapy for the treatment of osteosarcoma

2010177 citationsJournal Articlebronze Open Access

Authors

Paul A. Meyers · Memorial Sloan Kettering Cancer Center

John H. Healey · Memorial Sloan Kettering Cancer Center

Alexander J. Chou · Memorial Sloan Kettering Cancer Center

Leonard H. Wexler · Memorial Sloan Kettering Cancer Center

Pamela R. Merola · Memorial Sloan Kettering Cancer Center

Carol D. Morris · Memorial Sloan Kettering Cancer Center

Michael P. LaQuaglia

Abstract

Pamidronate can be safely incorporated with chemotherapy for the treatment of osteosarcoma. It does not impair the efficacy of chemotherapy. Pamidronate may improve the durability of limb reconstruction.

Topics & Keywords

Sarcoma Diagnosis and Treatment Bone health and treatments Bone Tumor Diagnosis and Treatments

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Cancer

Volume 117, Issue 8, pp. 1736-1744

DOI: 10.1002/cncr.25744

Field-Weighted Citation Impact: 5.77